April 13, 2009

Marketing Drives People To Antipsychotics For Depression

I'm sure most of you know that Abilify is an atypical antipsychotic that's been repurposed as an add-on treatment for depression. As I noted earlier this year, since that FDA approval Abilify's sales exploded by 30 percent in 2008. The company has massively advertised the drug for depression in print media and on TV and here's the dynamic that has led to, according to the Los Angeles Times.

"About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify 'might be right for them.' Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings. Mostly, they were depressed or anxious, and frustrated by the pace of their recovery.

"Leuchter wondered what was up: Depressed patients didn't usually seek out drugs used to quell psychiatry's most disturbing symptoms.

"What was up, he soon discovered, was spending on a new advertising campaign touting Abilify as an 'add-on' treatment for depression."

I've been criticizing these ads since they first began appearing last Fall, so it's nice to see the LAT walking in my footsteps, so to speak. I've asked the FDA questions about the drug being advertised as an anti-depressant when it's clearly an antipsychotic and has all of the health risks associated with those very, very powerful drugs. Of course, the FDA has had little to say.

Fortunately, there are some critics within medicine of this very strange trend:

"In the process, the spreading use of these costly drugs is raising -- for the nation as well as individual patients -- the rates and the risks of weight gain, diabetes, strokes, fatal heart attacks, an array of movement disorders and potentially, suicide, according to a wide range of critics.

"'This is very worrisome; frankly I have serious concerns about these drugs,' says Dr. Steven Nissen, who is chairman of the Cleveland Clinic's cardiovascular medicine department and serves as an ad hoc advisor for FDA panels. Studies point to a 'very questionable balance between efficacy and safety' for the class, he said. But that message, he said, has been lost in an apparent 'marketing bonanza' for the companies that make the medications. A recent report by the consulting firm Decision Resources found the makers of the atypicals spent $993 million in 2006 to promote the drugs to doctors and patients."

And here's another critic:

"'The story's pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing,' says Robert Rosenheck, a psychiatrist at Yale University who has studied the effectiveness and expanded use of the atypical antipsychotics. 'We know now what these companies' strategies are: The number of people with schizophrenia is limited, so the road to profitability goes through soccer moms. They need to market these drugs to ordinary people who have dissatisfactions in life.'"

Yes, let's medicate the soccer moms.

I've written loads about Abilify and you can read my back catalog here.

Posted by Philip Dawdy at April 13, 2009 11:38 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

Yes, antipsychotics are very powerful drugs with many adverse reactions. To add them to an antidepressant will cause even more side effects. Remember, too, that antipsychotics are also half antidepressant. So the likelyhood of being stuck down by serotonin syndrome or even neuroleptic malignant syndrome is more likely with this combination.

BTW, the antidepressants are also very powerful drugs. A man from California, by the name of Dave Short, graciously looked through the files of www.SSRIstories.com

He found, that just by using media articles, SSRI Stories was able to document 198 people on SSRIs or SNRIs who died from the side effects listed for antidepressants, 1,415 people who were murdered by someone who was either on an antidepressant or withdrawing from one and 627 people who committed suicide while taking an antidepressant.

So, both of these classes of psychiatric drugs are powerful drugs and can be extremely dangerous drugs. To take the two together is asking for a real tragedy. I hope physicians wake-up and start to use some common sense.

Posted by: Rosie at April 13, 2009 12:05 PM

It's an absolute joke. The lack of efficacy and great potential risks of each of these classes of drugs has been acknowledged even by the FDA. Neither class is safe or efficacious on its own so now we're supposed to believe that prescribed together they somehow are? This isn't logical. The gullibility and/or desperation of medical professionals and patients alike seems to know no bounds. And the risk of serotonin syndrome which seems to be ill understood despite the fact it's occurring frequently is increasing by the minute.

Posted by: Sara at April 13, 2009 12:44 PM

Steve Nissan forgot to mention DEATH from profound hyperglycemia as a result of Zyprexa and, I am sure, as a result of the other atypical antipschycotics.

Lest we never forget...the subtle symptoms of hyperglycemia ....excessive thirst, excessive peeing, weakness (have to sit down, so weak), vomiting....all out of the blue, none understood or ever warned about. Death seems to be currently being left off the description: After one gets to diabetes, there now seems to be a period added. Don't ever forget the rest: Hyperglycemia and death.

Posted by: greedanddeath at April 13, 2009 02:24 PM

Suicide can be a grave risk when treating a patient with severe depression. One of the advantages of the newer SSRI antidepressants is a much lower lethality in overdose compared to the older tricyclics and MAOI's.

What about overdosing on an SSRI now along with Abilify or Seroquel or the like? I've not seen that addressed at all, though the risk would clearly be of concern to a prescribing psychiatrist.

Posted by: David B. at April 13, 2009 04:03 PM

Rosie, Dave Short tip is fascinating - do you have a link? Many thanks.

Posted by: Lilly NC at April 13, 2009 04:35 PM

David B. Suicide can be a grave risk when taking an SSRI. I don't call taking a drug that makes you intensely agitated and suicidal less "lethal" than one that might kill you in overdose if you took several tablets. You don't need to take an overdose to die on Prozac, Paxil or Zoloft. Just take your standard dose and you might hang, shoot or stab yourself -- and maybe some others while you're at it!

Posted by: Sara at April 13, 2009 05:23 PM

SSRIs, SNRIs, atypicals....lookin' for RESEARCH about death at the beginning, middle, end, taper, off these suckers. Not there. Just spoke with a WORLD AUTHORITY about tapering off....lithium. NOTHING THERE. Of course the clinical trials re taking them in the first place is phony baloney.

No money in it(re such as tapering safely and then what happens after if you CAN get off) But clearly, for the vast majority of people I know of who are dead, the answer is " Don't EVER start in the first place."

Posted by: Prozac,Paxil,Zoloft etc. at April 13, 2009 08:29 PM

Hi Lilly,

Dave Short sent me the graph [with the stats on SSRI Stories] via an excel spreadsheet. I transposed it into an attachment for email.

I will find out tomorrow if my hubby can figure out how to make it into a link. Then I will post it to Furious Seasons.

I am glad you are interested because Dave Short worked long, hard hours on this for about two weeks.

Posted by: Rosie at April 13, 2009 08:43 PM

Please don't wait for the FDA to do or say anything constructive.....I for one don't want you to keel over in a dead faint from holding your breath!

Posted by: sorrowful at April 13, 2009 09:15 PM

Perhaps the drug company was hoping to create a market for Abilify? You know, create a need where one didn't exist? Living with bipolar myself I was acutely aware when the bus stop posters and the TV commercials for Abilify started appearing a couple of years ago. The term bipolar (or manic-depressive) wasn't on most people's radar before then. Now its becoming the "in" disease. But not fast enough for them. They need to convert all of the depressives who are currently taking those low-cost generic drugs into Abilify users. But folks, it is not a cure. There is no cure. Thirty years of trial-and-error has taught me that. I finally swore off drugs for good when Lamictal pushed me to the edge of suicide. There has to be a better solution. For me, taking medications not only did not work, they kept me feeling like a patient, like I was ill, which only reinforced the disease. I am happy for those who get temporary relief from the drugs, but I worry about the long term effects, both psychologically and physically.

Posted by: Marco Dante at April 14, 2009 03:30 PM

Rosie, thanks.

Posted by: Lilly NC at April 15, 2009 08:22 AM

I do not know where to begin - so I will just make a list.

1) Having BP II, I spend most of my time depressed. Abilify twice (two seperate trials) sent me into the worst mania - i.e. no sleep, jabbering like a money, flight of ideas, ... of my life.

2) I read the recent Newsweek article on epilepsy and said - that is me! Only the psych symptoms. Even a red flashing light can set off psych symptoms.

3) Another writer has suggested there is a reason that temporal lobe epilepsy can be confused with bipolar disease. He did not however mention that the amygdala is part of the mid temporal lobe. What if BP is just epilepsy of the amydala?

4) Interesting that anti-eplileptics are often used for BP and can have an anti-depressant effect.

So WHY in the world would anyone think that anti-psychotics are a good adjunctive therapy for depression OR bipolar. Simple $$s.

When I was trying Abilify, I was astounded to find that a 30 day supply of 2 mg tabs was $520! Fortunately I have insurance. Unfortunately, this is why medical costs are so high.

(I also was put on a trial of Seroquel. Slept for 18 hours - even at a min dose. Guess that anti-psychotic was too much for my tired liver (all those meds).)

So I say - you are SO right. We are being sold a bill of goods, for the purpose of profit. Anti-psychotics have terrible side effects and should be reserved for those who are psychotic!

BPIIGirl

Posted by: BPIIGirl at April 19, 2009 11:59 PM
Post a comment









Remember personal info?






pic1.jpg

Winter Fundraiser Underway!!!
Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Recent Entries
Winter Fundraiser, An Early Start
Reasons To Be Skeptical Of "Female Viagra" Drug, Big Pharma's Spanish Fly
Medical Marijuana For Autism?
AstraZeneca Whines About Chicago Tribune's Seroquel Coverage
Big Pharma's Sneaky Trick
Researchers Ignore Problems With Meds In Early Deaths, Blame Smoking, No Exercise
Researchers' New Pediatric Bipolar Disorder Symptoms Include Bed Wetting, Nightmares
Fort Hood Shooting: Was Psychiatrist-Shooter Psychotic Or A Terrorist?
Yale Researcher Links Childhood ADHD To Adult Crime, Drug Dealing
Senator Wants Pentagon To Account For Troop Anti-Depressant Use, Suicide Link
British Government To Limit Antipsychotic Use For Dementia
Child Psychiatrists Behaving Badly With Children
Utah Settles Zyprexa Claims For $24 Million
Psychiatrist Got $490,000 Pimping For Seroquel, Engaged In Wide Off-Label Use
Why Auto Insurance And Health Insurance Aren't The Same, Mr. President
Recent Comments

BPIIGirl on Marketing Drives People To Antipsychotics For Depression

Lilly NC on Marketing Drives People To Antipsychotics For Depression

Marco Dante on Marketing Drives People To Antipsychotics For Depression

sorrowful on Marketing Drives People To Antipsychotics For Depression

Rosie on Marketing Drives People To Antipsychotics For Depression

Prozac,Paxil,Zoloft etc. on Marketing Drives People To Antipsychotics For Depression

Sara on Marketing Drives People To Antipsychotics For Depression

Lilly NC on Marketing Drives People To Antipsychotics For Depression

David B. on Marketing Drives People To Antipsychotics For Depression

greedanddeath on Marketing Drives People To Antipsychotics For Depression

Archives
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Search


Powered by
Movable Type 3.2